There's no established dose conversion, so you would typically stop tirzepatide and start retatrutide at its lowest dose, titrating up slowly
The companies are licensed to make slightly different versions of FDA-approved drugs in response to shortages or a patients special needs
Results were consistent across biological sex, age, race, and type 2 diabetes status
Oriental Yeast, Tokyo, Japan) ad libitum during the experimental period
At the border, be straightforward if asked about what you are bringing across
But what was striking is the challenge, and this is one of the first important questions about, when you had the extended half-life of the first GLP-1 drug, that instead of having to take multiple times a day, you could actually, with liraglutide get to a point where you were starting to get to an extended half-life